Reaktionsgleichung
[OH:1][C@H:2]([C@H:6]([C:18]1[CH:23]=[CH:22][C:21]([O:24][CH3:25])=[CH:20][CH:19]=1)[S:7][C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][C:9]=1[NH:14]C(=O)C)[C:3]([OH:5])=[O:4]>O>[OH:1][C@H:2]([C@H:6]([C:18]1[CH:19]=[CH:20][C:21]([O:24][CH3:25])=[CH:22][CH:23]=1)[S:7][C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][C:9]=1[NH2:14])[C:3]([OH:5])=[O:4]Komponenten
3
Edukt 1
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
A process for the preparation of 2S-cis-hydroxy-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4-(5H)-one, in which (2S,3S)-2-hydroxy-3-(4-methoxyphenyl)-3-(2-acetylaminophenylthio)propionic acid (I) is subjected to prolonged ebollition with 1 to 5 moles of mineral acid which is diluted with water in 1:25 to 1:50 ratios.
Quellen und Nachweise
- ORD-Eintrag
- ord-16c6e7f173464a91b4cfba03421ae737
- Quelldatensatz
- uspto-grants-1991_05
- Patentnummer
- US05013834
Verknüpfte Notizen
Wird geladen…